Business Description
![Encompass Health Corp Encompass Health Corp logo](https://static.gurufocus.com/logos/0C00000B8T.png?14)
Encompass Health Corp
NAICS : 621498
SIC : 8093
ISIN : US29261A1007
Compare
Compare
Traded in other countries / regions
EHC.USAHSOA.GermanyEHC.Mexico IPO Date
2016-07-13Description
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.68 | |||||
Debt-to-EBITDA | 2.75 | |||||
Interest Coverage | 5.35 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.7 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.9 | |||||
3-Year EBITDA Growth Rate | 10.9 | |||||
3-Year EPS without NRI Growth Rate | 22.1 | |||||
3-Year FCF Growth Rate | -4.2 | |||||
3-Year Book Growth Rate | 0.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14.74 | |||||
Future 3-5Y Total Revenue Growth Rate | 10.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.5 | |||||
9-Day RSI | 56.55 | |||||
14-Day RSI | 55.55 | |||||
6-1 Month Momentum % | 30 | |||||
12-1 Month Momentum % | 35.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 0.2 | |||||
Days Sales Outstanding | 41.44 | |||||
Days Payable | 261.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.71 | |||||
Dividend Payout Ratio | 0.15 | |||||
3-Year Dividend Growth Rate | -18.8 | |||||
Forward Dividend Yield % | 0.71 | |||||
5-Year Yield-on-Cost % | 0.43 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 2.85 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 95.5 | |||||
Operating Margin % | 15.35 | |||||
Net Margin % | 7.6 | |||||
FCF Margin % | 4.83 | |||||
ROE % | 24.13 | |||||
ROA % | 6.3 | |||||
ROIC % | 11.19 | |||||
ROC (Joel Greenblatt) % | 22.18 | |||||
ROCE % | 14.65 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.83 | |||||
Forward PE Ratio | 21.79 | |||||
PE Ratio without NRI | 21.77 | |||||
Shiller PE Ratio | 23.89 | |||||
Price-to-Owner-Earnings | 38.63 | |||||
PEG Ratio | 9.07 | |||||
PS Ratio | 1.73 | |||||
PB Ratio | 4.88 | |||||
Price-to-Tangible-Book | 45.11 | |||||
Price-to-Free-Cash-Flow | 35.89 | |||||
Price-to-Operating-Cash-Flow | 9.97 | |||||
EV-to-EBIT | 14.44 | |||||
EV-to-Forward-EBIT | 14.91 | |||||
EV-to-EBITDA | 10.63 | |||||
EV-to-Forward-EBITDA | 10.76 | |||||
EV-to-Revenue | 2.28 | |||||
EV-to-Forward-Revenue | 2.13 | |||||
EV-to-FCF | 47.24 | |||||
Price-to-Projected-FCF | 2.19 | |||||
Price-to-DCF (Earnings Based) | 1.9 | |||||
Price-to-DCF (FCF Based) | 3.12 | |||||
Price-to-Median-PS-Value | 1.39 | |||||
Price-to-Graham-Number | 6.61 | |||||
Earnings Yield (Greenblatt) % | 6.93 | |||||
FCF Yield % | 2.81 | |||||
Forward Rate of Return (Yacktman) % | 5.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Encompass Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4,580.594 | ||
EPS (TTM) (€) | 3.419 | ||
Beta | 0.73 | ||
Volatility % | 18.69 | ||
14-Day RSI | 55.55 | ||
14-Day ATR (€) | 0.771481 | ||
20-Day SMA (€) | 77.6 | ||
12-1 Month Momentum % | 35.65 | ||
52-Week Range (€) | 56.5 - 80 | ||
Shares Outstanding (Mil) | 100.69 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Encompass Health Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Encompass Health Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Encompass Health Corp Frequently Asked Questions
What is Encompass Health Corp(STU:HSOA)'s stock price today?
The current price of STU:HSOA is €78.50. The 52 week high of STU:HSOA is €80.00 and 52 week low is €56.50.
When is next earnings date of Encompass Health Corp(STU:HSOA)?
The next earnings date of Encompass Health Corp(STU:HSOA) is 2024-08-01 Est..
Does Encompass Health Corp(STU:HSOA) pay dividends? If so, how much?
The Dividend Yield %  of Encompass Health Corp(STU:HSOA) is 0.71% (As of Today), Highest Dividend Payout Ratio of Encompass Health Corp(STU:HSOA) was 0.56. The lowest was 0.15. And the median was 0.34. The  Forward Dividend Yield % of Encompass Health Corp(STU:HSOA) is 0.71%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |